Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
- +86-0635-6175299
- li_ye@inyelchem.com
Shandong Haohong Biotechnology Co., Ltd.
- Casa
-
Elenco prodotti
-
- Alectinib Intermedi
- Cabozantinib intermedi
- Intermedi Ceritinib
- Larotrectinib intermedi
- Intermedi Brigatinib
- Abemaciclib Intermedi
- Vemurafenib intermedi
- Ponatinib intermedi
- Rucaparib intermedi
- Lenvatinib intermedi
- Gilteritinib intermedi
- Pomalidomide Intermedio
- Ruxolitinib intermedi
- Intermedi di lenalidomide
Ingrediente farmaceutico attivo (API)
- Enzalutamide API
- Apalutamide API
- Cabozantinib API
- Baricitinib API
- Alecitinib API
- Ceritinib API
- Tofacitinib API
- Macitentan API
- Ponatinib API
- Larotrectinib API
- Vemurafenib API
- Gilteritinib API
- Empagliflozin API
- Pomalidomide API
- Regorafenib API
- Palbociclib API
- Regorafenib idrato
- Lenalidomide API
- API Rivaroxaban
- API Apixaban
- Ruxolitinib API
- Chi siamo
- video
- Contatti
- Invia domanda